Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cells for Thin Endometrium
NCT03724617Completed
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Oct 2018
- Primary completion
- Jun 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of human umbilical cord mesenchymal stem cells in thin endometrium, sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Change of endometrial thickness at 6 months. Started Oct 2018; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
thin endometrium
Beyond the preview
Go deeper on NCT03724617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03724617.